跳至主要内容
临床试验/CTRI/2017/06/008903
CTRI/2017/06/008903进行中(未招募)未知

A randomized, double blind, controlled clinical trial to assess the Efficacy and safety of liposomal Curcumin compared with Curcumin (non-liposomal) on inflammation in subjects with metabolic syndrome

CureSupport0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. 18 years of age and above
  • 2. Metabolic abnormalities with or without alcohol consumption and/or smoking
  • 3. Diagnosis of MetS ie. the presence of three or more criteria of the modified National Cholesterol Education Programs Adult Treatment Panel III ( NCEP ATP III):
  • 3.1 Waist circumference 90 cm in men and 80 cm in women
  • 3.2 Hypertriglyceridemia >= 150 mg/dl
  • 3.3 High density lipoprotein (HDL) cholesterol 40 mg/dl in males and 50 mg/dl in females
  • 3.4 Blood pressure >= 130/85 mm Hg
  • 3.5 Fasting plasma glucose >= 110 mg/dl
  • 4.0 Patients willing to provide written informed consent

排除标准

  • 1. Pregnancy or breastfeeding,
  • 2. lack of compliance with the study medication (defined as not using the medication for >1 week),
  • 3. Participation in a concomitant trial,
  • 4. Hypersensitivity to the study medication,
  • 5. Presence of malignancies
  • 6. Impossibility to give informed consent.
  • 7. Intake of drugs or dietary supplements
  • 8. Previous illnesses such as heart attack, cancer or dementia
  • 9. Addiction illness

研究者

发起方
CureSupport

相似试验